[1]赵 丹,梁 斌,王 勇,等.肝癌化疗栓塞后溶瘤综合征1例 [J].介入放射学杂志,2018,27(05):461-463.
 ZHAO Dan,LIANG Bin,WANG Yong,et al.Tumor lysis syndrome after transcatheter arterial chemoembolization: report of one case[J].journal interventional radiology,2018,27(05):461-463.
点击复制

肝癌化疗栓塞后溶瘤综合征1例 
()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
27
期数:
2018年05期
页码:
461-463
栏目:
病例报道
出版日期:
2018-05-25

文章信息/Info

Title:
Tumor lysis syndrome after transcatheter arterial chemoembolization: report of one case
作者:
赵 丹 梁 斌 王 勇 郑传胜
Author(s):
ZHAO Dan LIANG Bin WANG Yong ZHENG Chuansheng
Department of Radiology, Affiliated Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province 430022, China
关键词:
【关键词】 溶瘤综合征 肝细胞癌 化疗栓塞 并发症
文献标志码:
A

参考文献/References:

[1] Kalff A, Shortt J, Farr J, et al. Laboratory tumor lysis syndrome complicating LBH589 therapy in a patient with acute myeloid leukaemia[J]. Haematologica, 2008, 93: e16- e17.
[2] Zivin SP, Elias Y, Ray CE Jr. Tumor lysis syndrome and primary hepatic malignancy: case presentation andreview of the literature[J]. Semin Intervent Radiol, 2015, 32: 3- 9.
[3] Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification[J]. Br J Haematol, 2004, 127: 3- 11.
[4] Davidson MB, Thakkar S, Hix JK, et al. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome[J]. Am J Med, 2004, 116: 546- 554.
[5] Howard SC, Jones DP, Pui CH. The tumor lysis syndrome[J]. N Engl J Med, 2011, 364: 1844- 1854.
[6] Cairo MS, Coiffier B, Reiter A, et al. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus[J]. Br J Haematol, 2010, 149: 578- 586.
[7] Coiffier B, Altman A, Pui CH, et al. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence- based review[J]. J Clin Oncol, 2008, 26: 2767- 2778.
[8] Howard SC, Trifilio S, Gregory TK, et al. Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review[J]. Ann Hematol, 2016, 95: 563- 573.
[9] Elliott MJ, Ronksley PE, Clase CM, et al. Management of patients with acute hyperkalemia[J]. CMAJ, 2010, 182: 1631- 1635.

相似文献/References:

[1]叶强.PEIT治疗肝脏恶性肿瘤[J].介入放射学杂志,1998,(01):24.
[2]叶强.肝脏肿瘤的经皮穿刺治疗:技术现状[J].介入放射学杂志,1998,(01):16.
[3]HondaN,Guo Q,Uchida H,等.经皮穿刺灼热生理盐水注射治疗肝癌——一个替代酒精注射的方法[J].介入放射学杂志,1995,(02):121.
[4]刘鹏芝,韩金红,赵凤珍,等.肝癌介入治疗中导管和导丝系列的清洗和消毒[J].介入放射学杂志,1996,(01):50.
[5]罗正益,李兴跃.肝脏疾病的血管造影诊断[J].介入放射学杂志,1996,(01):26.
[6]罗正益,曾炳生,郝春志,等.小肝癌CT和血管造影诊断——自内向外顺序染色征象的意义[J].介入放射学杂志,1996,(01):30.
[7]张大海,顾伟中,叶强.肝细胞癌的非手术治疗[J].介入放射学杂志,2000,(02):122.
[8]张璐西,施海彬,刘 圣,等.ACE联合索拉非尼治疗BCLC C期肝细胞癌20例疗效分析[J].介入放射学杂志,2014,(11):954.
 ZHANG Lu xi,SHI Hai bin,LIU Sheng,et al.Transarterial chemoembolization combined with sorafenib for hepatocellular carcinoma in BCLC C stage: clinical analysis of 20 cases[J].journal interventional radiology,2014,(05):954.
[9]张 雯,李 说,颜志平,等.植入性门静脉主干癌栓兔模型建立及评估[J].介入放射学杂志,2015,(09):801.
 ZHANG Wen,LI Shuo,YAN Zhi- ping,et al.Implanted main portal venous tumor thrombus model in experimental rabbits: its establishment and evaluation[J].journal interventional radiology,2015,(05):801.
[10]游建雄,王精兵,艾松涛,等.微球联合碘油栓塞治疗肝癌的近期疗效分析 [J].介入放射学杂志,2017,(06):531.
 YOU Jianxiong,WANG Jingbing,AI Songtao,et al.TACE by using microspheres and lipiodol for the treatment of hepatocellular carcinoma: analysis of short- term efficacy[J].journal interventional radiology,2017,(05):531.

备注/Memo

备注/Memo:
(收稿日期:2017-07-18)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2018-05-13